{"id":38,"date":"2018-06-19T12:27:29","date_gmt":"2018-06-19T12:27:29","guid":{"rendered":"http:\/\/web.aimgroupinternational.com\/2020\/sclerosiscongress\/?page_id=38"},"modified":"2020-05-12T13:40:48","modified_gmt":"2020-05-12T13:40:48","slug":"abstract-submission","status":"publish","type":"page","link":"https:\/\/web.aimgroupinternational.com\/2020\/sclerosiscongress\/abstract-submission\/","title":{"rendered":"ABSTRACT SUBMISSION AND TOPICS"},"content":{"rendered":"<section class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text]<span style=\"color: #000080; font-size: 24pt;\">Abstract Submission<\/span><strong><br \/>\n<\/strong><\/p>\n<p>The abstract will be structured in single headings:\u00a0<strong>Introduction, Material and Methods, Results and Conclusion<\/strong>.<br \/>\nEach paper must not exceed\u00a0<strong>400 words, NO figures, tables and references <\/strong><strong>will be accepted in the body of the abstract.<\/strong><strong><br \/>\nOnly JPG files, up to 500KB, for\u00a0X Ray, CT scan, NMR, pictures of skin, fingers and so on\u00a0can be uploaded<\/strong>, following the relative instructions after the body of the abstract.<\/p>\n<p>[\/vc_column_text]<div class=\"divider empty-space\" style=\"text-align:left;\"><div class=\"divider-elm empty-space\" style=\"margin-top:30px; \"><\/div><\/div>[vc_column_text]<span style=\"color: #ff0000;\"><strong><span style=\"font-size: 14pt;\">SUBMISSION IS CLOSED<\/span><\/strong><\/span>[\/vc_column_text][vc_column_text]For information please contact: \u00a0<a href=\"mailto:ssc2020.abstract@aimgroup.eu\">ssc2020.abstract@aimgroup.eu<\/a>[\/vc_column_text]<div class=\"divider empty-space\" style=\"text-align:left;\"><div class=\"divider-elm empty-space\" style=\"margin-top:35px; \"><\/div><\/div>[vc_column_text]<span style=\"color: #000080;\"><strong>DEADLINES<\/strong><\/span><br \/>\nAbstract submission: <strong><del>Monday, September 23, 2019<\/del> extended to Monday, September 30, 2019<\/strong><br \/>\nEarly bird registration fee: <strong>Monday, December 2, 2019<\/strong><br \/>\nNotification to Authors: <strong>Friday, December 20, 2019<\/strong><span style=\"font-size: 12pt;\"><br \/>\n<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #000080;\"><strong>ENCORE ABSTRACTS<\/strong><\/span><br \/>\nEncore abstracts are admitted but it is not allowed to submit the very same abstract presented elsewhere. It is important to have at least a new aspect and\/or analysis within more data or emphasis on different\/additional interpretation.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #000080;\"><strong>INSTRUCTIONS TO AUTHORS<\/strong><\/span><br \/>\nThe corresponding author is responsible for the abstract. Please note that only the corresponding author will receive mail concerning the abstract and is responsible for informing all co-authors of the status of the abstract. The corresponding author can be a first author or not.<br \/>\nWhen the Scientific Committee will have evaluated all the received papers, the abstracts correspondents will receive all the information and necessary elements by mail.<br \/>\nAccepted abstracts will be published on the \u201c<em>JSRD<\/em> &#8211; <em>Journal of Scleroderma and Related Disorders\u201d<\/em>.<br \/>\nEach abstract will be published as submitted. The organizers do not accept any responsibility for the accuracy of the abstracts.<\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #000080;\"><strong>TOPICS<\/strong><\/span><\/p>\n<ol>\n<li>1. Pathogenesis (Autoantibodies)<\/li>\n<li>2. Pulmonary including Interstitial Lung Disease and Pulmonary<\/li>\n<li>3. Arterial Hypertension<\/li>\n<li>4. Cardiac<\/li>\n<li>5. Outcomes, Quality of Life, Psychological &amp; Social<\/li>\n<li>6. Imaging<\/li>\n<li>7. Vascular<\/li>\n<li>8. Renal<\/li>\n<li>9. Musculoskeletal System &amp; Rehabilitation<\/li>\n<li>10. Gastrointestinal\/Nutrition<\/li>\n<li>11. Gender Related Issues<\/li>\n<li>12. Recent Advances in Therapy (case series for new treatment)<\/li>\n<li>13. Pediatric Scleroderma<\/li>\n<li>14. Sclerosing skin diseases (Localized scleroderma)<\/li>\n<li>15. Emerging therapies (pre-clinical)<\/li>\n<li>16. Case reports<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p>For information about abstract submission please contact:<br \/>\n<strong>AIM Group International \u2013 Rome office<\/strong><br \/>\nVia Flaminia 1068 \u2013 00189 Rome, Italy<br \/>\nTel. +39 06 33053.1 \u2013 Fax +39 06 33053.249 &#8211; E-mail: <a href=\"mailto:ssc2020.abstract@aimgroup.eu\">ssc2020.abstract@aimgroup.eu<\/a>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text]Abstract Submission The abstract will be structured in single headings:\u00a0Introduction, Material and Methods, Results and Conclusion. Each paper must not exceed\u00a0400 words, NO figures, tables and references will be accepted in the body of the abstract. Only JPG files, up to 500KB, for\u00a0X Ray, CT scan, NMR, pictures of skin,&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-38","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/web.aimgroupinternational.com\/2020\/sclerosiscongress\/wp-json\/wp\/v2\/pages\/38"}],"collection":[{"href":"https:\/\/web.aimgroupinternational.com\/2020\/sclerosiscongress\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/web.aimgroupinternational.com\/2020\/sclerosiscongress\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/web.aimgroupinternational.com\/2020\/sclerosiscongress\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/web.aimgroupinternational.com\/2020\/sclerosiscongress\/wp-json\/wp\/v2\/comments?post=38"}],"version-history":[{"count":29,"href":"https:\/\/web.aimgroupinternational.com\/2020\/sclerosiscongress\/wp-json\/wp\/v2\/pages\/38\/revisions"}],"predecessor-version":[{"id":742,"href":"https:\/\/web.aimgroupinternational.com\/2020\/sclerosiscongress\/wp-json\/wp\/v2\/pages\/38\/revisions\/742"}],"wp:attachment":[{"href":"https:\/\/web.aimgroupinternational.com\/2020\/sclerosiscongress\/wp-json\/wp\/v2\/media?parent=38"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}